Constrictive pericarditis laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Hudakarman (talk | contribs) |
Hudakarman (talk | contribs) |
||
Line 13: | Line 13: | ||
** Leukocytosis | ** Leukocytosis | ||
** Infectious, bacteriologic, or rheumatologic source or steroid therapy | ** Infectious, bacteriologic, or rheumatologic source or steroid therapy | ||
** | *** Leukopenia | ||
*** malignancy and chemotherapeutic agents use <br /> | |||
* | * | ||
Revision as of 20:49, 23 December 2019
Constrictive Pericarditis Microchapters |
Differentiating Constrictive Pericarditis from other Diseases |
---|
Treatment |
Case Studies |
Constrictive pericarditis laboratory findings On the Web |
American Roentgen Ray Society Images of Constrictive pericarditis laboratory findings |
Risk calculators and risk factors for Constrictive pericarditis laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Pericardial constriction has been associated with, protein losing enteropathy, nephrotic syndrome, and LFT abnormalities consistent with hepatic congestion and chylous ascites.
Laboratory findings
- Complete blood count (CBC)
- Dilutional anemia if congestive heart failure (CHF) is present.
- Leukocytosis
- Infectious, bacteriologic, or rheumatologic source or steroid therapy
- Leukopenia
- malignancy and chemotherapeutic agents use